Beranda › Leukemia Mieloid Akut › California › Baldwin Park
Uji klinis Leukemia Mieloid Akut di Baldwin Park, CA
40 studi untuk Leukemia Mieloid Akut mencari peserta di lokasi sekitar Baldwin Park (dalam radius sekitar 30 mil). Buka studi untuk melihat kriteria peserta dan cara menghubungi tim studi.
Teks studi resmi (Bahasa Inggris)
Merekrut peserta untuk studi di sini? Tampilkan di bagian atas halaman ini — $99 selama 30 hari →
A Study to Assess Adverse Events and Change in Disease Activity When Intravenous (IV) Pivekimab Sunirine is Given in Combination With Oral Venetoclax and IV or Subcutaneous Azacitidine in Adult Participants With Acute Myeloid Leukemia (AML)
Menerima pesertaFase 2/3
- City of Hope National Medical Center /ID# 279568, Duarte · 4 mi jauhnya
A Phase 1 Study of Orca-Q in Recipients Undergoing Allogeneic Transplantation for Hematologic Malignancies
Menerima pesertaFase 1
- City of Hope, Duarte · 4 mi jauhnya
A Phase 1 Study of AOH1996 in Patients With Relapsed/Refractory Acute Myeloid Leukemia
Menerima pesertaFase 1
- City of Hope Medical Center, Duarte · 4 mi jauhnya
Study of Revumenib in Combination With Intensive Chemotherapy in Newly Diagnosed Acute Myeloid Leukemia (AML) With a NPM1 Mutation
Menerima pesertaFase 3
- Clinical Trial Site, Duarte · 4 mi jauhnya
A Study of Bleximenib, Venetoclax and Azacitidine For Treatment of Participants With Newly Diagnosed Acute Myeloid Leukemia (AML)
Menerima pesertaFase 3
- City of Hope, Duarte · 4 mi jauhnya
A Study to Compare Standard Chemotherapy to Therapy With CPX-351 and/or Gilteritinib for Patients With Newly Diagnosed AML With or Without FLT3 Mutations
Menerima pesertaFase 3
- City of Hope Comprehensive Cancer Center, Duarte · 4 mi jauhnya
(Apex) Bezuclastinib in Patients With Advanced Systemic Mastocytosis
Menerima pesertaFase 2
- City of Hope Comprehensive Cancer Center, Duarte · 4 mi jauhnya
Phase 1 Study of AUTX-703 in Relapsed/Refractory AML and MDS
Menerima pesertaFase 1
- City of Hope National Medical Center, Duarte · 4 mi jauhnya
The Lowest Effective Dose of Post-Transplantation Cyclophosphamide in Combination With Sirolimus and Mycophenolate Mofetil as Graft-Versus-Host Disease Prophylaxis After Reduced Intensity Conditioning and Peripheral Blood Stem Cell Transplantation
Menerima pesertaFase 1/2Sukarelawan sehat diterima
- City of Hope, Duarte · 4 mi jauhnya
A Study to Assess the Safety, Tolerability, and Antileukemic Activity of Debio 1562M in Participants With Acute Myeloid Leukemia (AML)
Menerima pesertaFase 1/2
- City of Hope Comprehensive Cancer Center, Duarte · 4 mi jauhnya
Study of SLS009 (Formerly GFH009) a Potent Highly Selective CDK9 Inhibitor in Patients With Hematologic Malignancies and High-Risk Newly Diagnosed AML
Menerima pesertaFase 1/2
- City of Hope National Medical Center, Duarte · 4 mi jauhnya
MiRisten for the Treatment of Relapsed or Refractory Acute Myeloid Leukemia
Menerima pesertaFase 1
- City of Hope Medical Center, Duarte · 4 mi jauhnya
Eganelisib as Monotherapy and in Combination With Cytarabine in Relapsed/Refractory AML
Menerima pesertaFase 1
- City of Hope, Duarte · 4 mi jauhnya
8-Chloroadenosine in Combination With Venetoclax for the Treatment of Patients With Relapsed/Refractory Acute Myeloid Leukemia
Menerima pesertaFase 1
- City of Hope Medical Center, Duarte · 4 mi jauhnya
Individualized AML Treatment
Menerima pesertaStudi observasional
- City of Hope Medical Center, Duarte · 4 mi jauhnya
Total Marrow and Lymphoid Irradiation in Combination With Fludarabine and Melphalan as Conditioning for Allogeneic Peripheral Blood Stem Cell Hematopoietic Cell Transplant in Older Patients With Refractory and Relapsed Acute Myeloid Leukemia and High-risk Myelodysplastic Syndrome
Menerima pesertaFase 2
- City of Hope Medical Center, Duarte · 4 mi jauhnya
225Ac-DOTA-Anti-CD38 Daratumumab Monoclonal Antibody With Fludarabine, Melphalan and Total Marrow and Lymphoid Irradiation as Conditioning Treatment for Donor Stem Cell Transplant in Patients With High-Risk Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia and Myelodysplastic Syndrome
Menerima pesertaFase 1
- City of Hope Medical Center, Duarte · 4 mi jauhnya
A Vaccine (CMV-MVA Triplex Vaccine) for the Enhancement of CMV-Specific Immunity and the Prevention of CMV Viremia in Patients Undergoing Haploidentical Hematopoietic Stem Cell Transplant
Menerima pesertaFase 1Sukarelawan sehat diterima
- City of Hope Medical Center, Duarte · 4 mi jauhnya
Mocravimod as Adjunctive and Maintenance Treatment in AML Patients Undergoing Allo-HCT
Menerima pesertaFase 3
- City of Hope Comprehensive Cancer Center - Duarte, Duarte · 4 mi jauhnya
Tagraxofusp and Azacitidine for Maintenance Treatment in Patients With CD123 Positive AML and MDS Following Donor Hematopoietic Cell Transplant
Menerima pesertaFase 1
- City of Hope Medical Center, Duarte · 4 mi jauhnya
A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs)
Menerima pesertaStudi observasional
- City of Hope, Duarte · 4 mi jauhnya
Emapalumab With Post-Transplant Cyclophosphamide, Tacrolimus and Mycophenolate Mofetil for the Prevention of Graft-versus-Host Disease After Donor Reduced-Intensity Hematopoietic Cell Transplant
Menerima pesertaFase 1
- City of Hope Medical Center, Duarte · 4 mi jauhnya
Vedolizumab Plus Post-transplant Cyclophosphamide and Short Course Tacrolimus for the Prevention of Graft Versus Host Disease in Patients Undergoing Allogeneic Hematopoietic Cell Transplantation After Reduced Intensity Conditioning
Menerima pesertaFase 2
- City of Hope Medical Center, Duarte · 4 mi jauhnya
A Study of Revumenib and Mezigdomide in People With Leukemia
Menerima pesertaFase 1/2
- City of Hope Cancer Center (Data collection only), Duarte · 4 mi jauhnya
SL-401 in Combination With Azacitidine or Azacitidine/Venetoclax in Acute Myeloid Leukemia (AML), High-Risk Myelodysplastic Syndrome (MDS) or Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN)
Menerima pesertaFase 1
- City of Hope, Duarte · 4 mi jauhnya
Orca-T Following Chemotherapy and Total Marrow and Lymphoid Irradiation for the Treatment of Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia or Myelodysplastic Syndrome
Menerima pesertaFase 1Sukarelawan sehat diterima
- City of Hope Medical Center, Duarte · 4 mi jauhnya
Study of Talazoparib in Combination With Chemotherapy in Relapsed Pediatric AML to Determine Safety and Efficacy
Menerima pesertaFase 1
- City of Hope, Duarte · 4 mi jauhnya
A Study of GLB-001 in Patients With Relapsed or Refractory Acute Myeloid Leukemia or Relapsed or Refractory Higher Risk Myelodysplastic Syndromes
Menerima pesertaFase 1
- City of Hope Medical Center, Duarte · 4 mi jauhnya
A Platform Protocol to Investigate Post-Transplant Cyclophosphamide-Based Graft-Versus-Host Disease Prophylaxis in Patients With Hematologic Malignancies Undergoing Mismatched Unrelated Donor Peripheral Blood Stem Cell Transplantation
Menerima pesertaFase 2
- City of Hope, Duarte · 4 mi jauhnya
A Study of CBX-250 in Participants With Relapsed or Refractory Myeloid Leukemias
Menerima pesertaFase 1
- City of Hope, Duarte · 4 mi jauhnya
CMV-MVA Triplex Vaccination in HLA-Matched Related Stem Cell Donors for the Prevention of CMV Infection in Patients Undergoing Hematopoietic Stem Cell Transplant
Menerima pesertaFase 2Sukarelawan sehat diterima
- City of Hope Medical Center, Duarte · 4 mi jauhnya
CD33-CAR T Cell Therapy for the Treatment of Recurrent or Refractory Acute Myeloid Leukemia
Menerima pesertaFase 1
- City of Hope Medical Center, Duarte · 4 mi jauhnya
Olutasidenib for the Treatment of Patients With IDH1 Mutated AML, MDS or CMML After Donor Hematopoietic Cell Transplant
Menerima pesertaFase 1
- City of Hope Medical Center, Duarte · 4 mi jauhnya
Revumenib for the Treatment of Acute Leukemia in Patients Post-Allogeneic Stem Cell Transplant
Menerima pesertaFase 1
- City of Hope Medical Center, Duarte · 4 mi jauhnya
Safety of MT-401-OTS in Patients With Relapsed AML or MDS
Menerima pesertaFase 1
- City of Hope Center (City of Hope National Medical Center, City of Hope Medical Center), Duarte · 4 mi jauhnya
Ruxolitinib With Tacrolimus and Methotrexate for the Prevention of Graft Versus Host Disease in Pediatric and Young Adult Patients Undergoing Allogeneic Hematopoietic Cell Transplant for Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, or Myelodysplastic Syndrome
Menerima pesertaFase 2
- City of Hope Medical Center, Duarte · 4 mi jauhnya
Study of NMS-03597812 in Adult Patients With Relapsed/Refractory Acute Myeloid Leukemia
Menerima pesertaFase 1
- City of Hope - Duarte, Duarte · 4 mi jauhnya
A Study of BH-30236 in Relapsed/ Refractory Acute Myelogenous Leukemia and Higher Risk Myelodysplastic Syndrome
Menerima pesertaFase 1
- City of Hope Medical Center, Duarte · 4 mi jauhnya
Study of REM-422 in Patients With AML or Higher Risk MDS
Menerima pesertaFase 1
- City of Hope, Duarte · 4 mi jauhnya
A Study of BTX-A51 in People With Relapsed or Refractory Acute Myeloid Leukemia or High-Risk Myelodysplastic Syndrome
Menerima pesertaFase 1
- City of Hope National Medical Center, Duarte · 4 mi jauhnya
Uji klinis Leukemia Mieloid Akut di kota lain
- Houston, TX85 studi
- New York City, NY51 studi
- Boston, MA44 studi
- Seattle, WA41 studi
- Columbus, OH35 studi
- Philadelphia, PA34 studi
- Durham, NC33 studi
- Atlanta, GA31 studi
- Tampa, FL29 studi
- Chicago, IL26 studi
- Portland, OR25 studi
- Washington, DC24 studi
Studi lain di Baldwin Park
- Kanker Payudara44 studi
- Kanker Kolorektal37 studi
- Kanker Paru Non-Sel Kecil36 studi
- Kanker (semua jenis)34 studi
- Kanker Prostat30 studi
- Kanker Metastatik30 studi
- Sindrom Mielodisplastik26 studi
- Kanker Ovarium25 studi
- Kanker Paru24 studi
- Mieloma Multipel23 studi
- Kanker Lambung22 studi
- Leukemia Limfoblastik Akut21 studi
Dari ClinicalTrials.gov, data diambil 6 Okt 2026. Setiap studi menetapkan kriteria kelayakannya sendiri; tim studi yang menentukan siapa yang bisa bergabung.